Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
October 31, 2016 Cover
Volume 94, Issue 43
Young companies powered by chemistry
Cover image:
Credit:
Vinpocetine: drug or dietary supplement?
FDA signals intent to regulate semisynthetic dietary ingredient as a drug
Switzerland’s hidden pharmaceutical hub
Ticino blends Italian entrepreneurialism with Swiss efficiency
-
Teaching social media to scientists
A handful of courses help researchers navigate the landscape of internet communication
-
Firms aim to fathom diseases
Genomics Medicine Ireland and BlackThorn Therapeutics get venture support for understanding diseases
-
Dow, DuPont raise earnings amid demand for cars, houses, and food
Chemical firms beat lackluster global economy by selling into consumer markets
ADVERTISEMENT
Science Concentrates
Cyclic peptides with heterocycles are cell membrane-permeable
Oxadiazole-containing peptidomimetic macrocycles have potential as drugs
